NCT05870748 |
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 |
NCT05766748 |
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer |
NCT06249048 |
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab |
NCT03351348 |
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control |
NCT06336148 |
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors |
NCT04616248 |
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors |
NCT04678648 |
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies |
NCT06650579 |
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial |
NCT06629779 |
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. |
NCT04792684 |
Collection of Samples USOPTIVAL Study |
NCT03011684 |
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial |
NCT03054584 |
Genetic Basis of Melanocytic Nevi |
NCT06321484 |
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer |
NCT04420702 |
Diffusion Basis Spectrum Imaging of the Prostate |
NCT04933084 |
Pre-operative Education Modalities to Decrease Opioid Use |
NCT06831084 |
Acute Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer Patients With the Use of Silver-Plated Technology |
NCT05935384 |
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation |
NCT03998202 |
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer |
NCT06691984 |
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer |
NCT05870579 |
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer |
NCT04080284 |
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma |
NCT05923684 |
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making |
NCT04762979 |
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer |
NCT06136884 |
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors |
NCT06599502 |
A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation |
NCT06336902 |
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients with KRAS-Mutant Metastatic Colorectal Cancer |
NCT05170802 |
Pancreatic Cancer & Surgical Resection |
NCT07020221 |
A Phase 1/2a Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors |
NCT00923221 |
Collection of Blood From Patients With Prostate Cancer |
NCT04038502 |
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer |
NCT06661902 |
Buffered Lidocaine for Reducing Pain in Patients Undergoing Prostate Biopsy, BURN Trial |
NCT06833502 |
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer |
NCT06353321 |
Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1 |
NCT06706921 |
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer |
NCT05984602 |
A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer |
NCT04990921 |
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer |
NCT06535802 |
iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men |
NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
NCT06631521 |
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer |
NCT05413421 |
Study of ORIC-944 in Patients with Metastatic Prostate Cancer |
NCT06401421 |
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) |
NCT05685602 |
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer |
NCT06323421 |
Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer |
NCT06428721 |
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population |
NCT04469764 |
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer |
NCT04698564 |
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging |
NCT04019964 |
Nivolumab in Biochemically Recurrent dMMR Prostate Cancer |
NCT06238921 |
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases |
NCT06036121 |
A Study of ADRX-0706 in Select Advanced Solid Tumors |
NCT06943521 |
A Study of MT-4561 in Patients With Various Advanced Solid Tumors |
NCT05743621 |
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer |
NCT06150664 |
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies |
NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients with Invasive Metastatic Breast Cancer |
NCT05919264 |
FOG-001 in Locally Advanced or Metastatic Solid Tumors |
NCT06327490 |
A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer |
NCT05949021 |
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer |
NCT05950464 |
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer |
NCT06824064 |
Evaluation of RBS2418 in Patients with Advanced, Metastatic, and Progressive Colorectal Cancer |
NCT05647564 |
PET/CT Characterization of Treatment Resistance |
NCT04968964 |
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing |
NCT05650021 |
Rectal Spacer for Prostate Cancer Radiation Image Guidance |
NCT02621021 |
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab |
NCT04759664 |
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC |
NCT06102902 |
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer |
NCT02594202 |
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue |
NCT04897321 |
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) |
NCT06873802 |
ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers |
NCT04821284 |
Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer |
NCT06580002 |
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial |
NCT04139902 |
Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) Vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma |
NCT06105684 |
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer |
NCT05926102 |
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) |
NCT04857502 |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer |
NCT05527184 |
First in Human Study of IMGN151 in Recurrent Gynaecological Cancers |
NCT04368702 |
CONFIRM: Magnetic Resonance Guided Radiation Therapy |
NCT05134779 |
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You |
NCT06237179 |
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk |
NCT05755984 |
3D Printed Breast Models in the Surgical Management of Breast Cancer |
NCT05398302 |
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy |
NCT05780684 |
Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer |
NCT06888102 |
A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer |
NCT05741164 |
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer |
NCT03833921 |
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer |
NCT05296421 |
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer |
NCT05689021 |
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations |
NCT05378464 |
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer |
NCT06888921 |
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer |
NCT04373564 |
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years |
NCT06105021 |
Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor |
NCT05786664 |
Breast Cancer Survivorship Biorepository |
NCT05423964 |
Impact of AI on Trainee ADR |
NCT06330064 |
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02) |
NCT05683964 |
Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression |
NCT06144164 |
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer |
NCT05559164 |
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted |
NCT06434064 |
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer |
NCT06112379 |
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer |
NCT05524584 |
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer |
NCT06750484 |
Trial of Trastuzumab Deruxtecan in Previously Treated HER2 |
NCT05419479 |
Switch Maintenance in Pancreatic |
NCT05675579 |
A Phase II Study of Neoadjuvant Sacituzumab Govitecan and Pembrolizumab Therapy for Immunochemotherapy-resistant Early-stage Triple-negative Breast Cancer (TNBC) |
NCT03941379 |
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma |
NCT05633979 |
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer |
NCT04820179 |
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer |
NCT05559879 |
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma |
NCT06238479 |
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors |
NCT04753879 |
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. |
NCT04986579 |
Scalp Cooling in MBC |
NCT06047379 |
Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis |
NCT06783179 |
Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement |
NCT02945579 |
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy |
NCT06439979 |
Rural Adult and Youth Sun Protection Study |
NCT06728579 |
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors |
NCT05050084 |
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial |
NCT05598879 |
Global Cardio Oncology Registry |
NCT06127979 |
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery |
NCT04683679 |
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer |
NCT05507879 |
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer |
NCT06108479 |
Study of DF6215 in Patients with Advanced Solid Tumors |
NCT01042379 |
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer |
NCT06917079 |
BBO-11818 in Adult Subjects With KRAS Mutant Cancer |
NCT04766190 |
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer |
NCT06272864 |
BostonGene and Exigent Genomic INsight Study |
NCT04913064 |
Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer |
NCT04363164 |
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression |
NCT06284590 |
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients |
NCT05200364 |
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer |
NCT05126290 |
CTNNA1 Familial Expansion Study |
NCT04354064 |
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors |
NCT05826964 |
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer |
NCT06518564 |
Avelumab and M1774 in ARID1A-mutated Endometrial Cancer (Prior IO) |
NCT06666790 |
DermaSensor Postmarket Surveillance Study |
NCT06270043 |
Focal Therapy for Localized Prostate Cancer |
NCT04863443 |
Nonlinear Elasticity Mapping of Breast Masses |
NCT05972343 |
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients |
NCT06864338 |
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test |
NCT06476808 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. |
NCT01607008 |
MRI for Assessing Prostate Cancer Response |
NCT06831838 |
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors |
NCT06216938 |
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis |
NCT05239338 |
Preserving Fertility After Colorectal Cancer Study |
NCT04396808 |
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer |
NCT05616650 |
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor |
NCT06049355 |
EMBRACE: Exercising Together |
NCT04585750 |
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) |
NCT06682650 |
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics) |
NCT06422455 |
Access to Genetic Testing in Underserved Patients With Cancer |
NCT03424850 |
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy |
NCT06400550 |
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis |
NCT06961955 |
5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer |
NCT05530655 |
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer |
NCT05301114 |
Social Risk Factors and Discrimination in Cancer Survivorship |
NCT05676255 |
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project |
NCT05715255 |
Adaptive Symptom Self-Management Immunotherapy Study |
NCT06617455 |
Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial |
NCT04729114 |
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer |
NCT06411795 |
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy |
NCT05780814 |
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer |
NCT06733350 |
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance |
NCT05568550 |
Pembro With Radiation With or Without Olaparib |
NCT04291755 |
Development and Analysis of a Stool Bank for Cancer Patients |
NCT06461650 |
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction |
NCT06058650 |
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities |
NCT06512350 |
Identifying Patterns in the Breath of Individuals With Breast Cancer |
NCT05086250 |
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer |
NCT05974150 |
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring |
NCT05413850 |
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection |
NCT06151223 |
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer |
NCT05447923 |
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities |
NCT03449238 |
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients |
NCT04929223 |
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) |
NCT06636123 |
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy |
NCT06234423 |
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors |
NCT04348123 |
Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography |
NCT05483023 |
18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy |
NCT05373823 |
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors |
NCT05779423 |
Cryoablation+Ipilimumab+Nivolumab in Melanoma |
NCT04986423 |
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer |
NCT06616155 |
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT05286814 |
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma |
NCT06051695 |
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression |
NCT06130995 |
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer |
NCT05014295 |
Patient Recall of Cancer Screening and Diagnosis |
NCT05069038 |
Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy |
NCT05030038 |
Oral Aromatase Inhibitors Modify the Gut Microbiome |
NCT06153238 |
A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma |
NCT04541108 |
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies |
NCT05919108 |
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers |
NCT06016738 |
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer |
NCT05720338 |
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy? |
NCT06006923 |
Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer |
NCT02313623 |
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research |
NCT06617923 |
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer |
NCT05732623 |
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer |
NCT06085664 |
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy |
NCT06257264 |
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors |
NCT06263543 |
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW MBC |
NCT04705038 |
Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments |
NCT04472338 |
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study |
NCT06103864 |
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer |
NCT04965064 |
Trial of Neratinib Plus Capecitabine in Subjects with HER2-Negative Metastatic Breast Cancer with Brain Metastases and Abnormally Active HER2 Signaling |
NCT05471414 |
Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer |
NCT04839614 |
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia |
NCT06112314 |
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) |
NCT04624555 |
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors |
NCT04049214 |
Perioperative Mindfulness Proposal |
NCT06659614 |
Prostate Tissue BioBank |
NCT05939414 |
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC. |
NCT04003038 |
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery |
NCT05827614 |
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), in Subjects With Tumors With Oncogene Amplifications |
NCT06562543 |
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer |
NCT01794403 |
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) for Prostate Cancer |
NCT05663203 |
A Web-Based Dyadic Intervention for Colorectal Cancer |
NCT02393703 |
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer |
NCT06200103 |
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer |
NCT03842943 |
Neoadjuvant Combination Immunotherapy for Stage III Melanoma |
NCT06349590 |
Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery |
NCT06187103 |
Evaluation of Improved Onboard Patient Imaging |
NCT04907643 |
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
NCT06956690 |
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ENV-501 in Patients With HER3-Expressing Solid Tumors |
NCT05381103 |
PSMA-PET to Guide Prostatectomy |
NCT05005403 |
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab |
NCT06738303 |
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer |
NCT06528990 |
Telehealth Intervention for Ostomy Self-Management |
NCT06218303 |
Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ |
NCT04005690 |
Targeted Pathway Inhibition in Patients With Pancreatic Cancer |
NCT06112990 |
Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression |
NCT05429203 |
Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope |
NCT06523803 |
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers |
NCT06470243 |
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body |
NCT06007690 |
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma |
NCT04658303 |
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma |
NCT05518903 |
Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma |
NCT05911243 |
Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer |
NCT05682443 |
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC |
NCT05826743 |
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy |
NCT05968690 |
Naltrexone and Propranolol Combined With Immunotherapy |
NCT05700903 |
Contributions to Hypertension With Androgen Deprivation Therapy |
NCT02775643 |
Molecular Analysis of Childhood and Adolescent Melanocytic Lesions |
NCT03456843 |
Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer |
NCT06677190 |
Belzutifan in Recurrent Clear Cell Ovarian Carcinoma |
NCT06441890 |
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer |
NCT05128890 |
Evaluation of Resection Techniques for Pancreatic Tumors |
NCT06705803 |
Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE) |
NCT06409390 |
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer |
NCT06067503 |
Biomarkers to Detect Endocrine Therapy Resistance |
NCT05223803 |
TERPS Trial for De Novo Oligometastic Prostate Cancer |
NCT06397703 |
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer |
NCT05505643 |
Cryoablation vs Lumpectomy in T1 Breast Cancers |
NCT05369546 |
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis |
NCT05049746 |
Identifying Decision Making Needs for Older Adult Women with Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy |
NCT02735746 |
Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis |
NCT06746012 |
Designing a Dyad-Based MHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers |
NCT05058846 |
Pilot Study of Pancreatic Cancer Screening |
NCT06787612 |
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer |
NCT06099769 |
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
NCT01365169 |
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" |
NCT06818812 |
A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation |
NCT01035112 |
Magnetic Resonance Imaging of Breast Cancer |
NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
NCT04031469 |
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease |
NCT06677112 |
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer |
NCT05839912 |
Excision of Lymph Node Trial (EXCILYNT) (Mel69) |
NCT05629546 |
Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors |
NCT05654246 |
Susan G. Komen's ShareForCures |
NCT06340646 |
Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) |
NCT06171269 |
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life |
NCT01102569 |
Pancreatic Cancer Genetics |
NCT06378346 |
GU-01: Glycyrrhizin in Prostate Cancer |
NCT06518746 |
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation |
NCT06698146 |
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection |
NCT06215469 |
Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads) |
NCT05155046 |
18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy |
NCT05755269 |
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women |
NCT03821246 |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy |
NCT05080946 |
Using Aspirin to Improve Immunological Features of Ovarian Tumors |
NCT06325046 |
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer |
NCT05396846 |
My Best GI Eating Study |
NCT04989946 |
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer |
NCT06678269 |
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer |
NCT05318469 |
Ivermectin and Balstilimab for the Treatment of Metastatic Triple Negative Breast Cancer |
NCT05113368 |
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer |
NCT04477343 |
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
NCT05396612 |
Role of the Immune Environment in Response to Therapy in Breast Cancer |
NCT06347068 |
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells |
NCT06027268 |
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer |
NCT04891068 |
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer |
NCT02977468 |
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer |
NCT03460769 |
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) |
NCT06865768 |
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique |
NCT06228768 |
Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer |
NCT04606446 |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors |
NCT06500169 |
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors |
NCT04611568 |
War on Melanoma™ Public Health & Education Campaign |
NCT06465368 |
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause |
NCT06067269 |
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial |
NCT07047872 |
A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction |
NCT05534646 |
Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer |
NCT06444269 |
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial |
NCT05703269 |
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy |
NCT06817668 |
Evaluating Tolerability of ePUHRT With Brachytherapy Boost |
NCT03611868 |
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors |
NCT04167969 |
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer |
NCT04365569 |
Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program |
NCT04687969 |
Multimodal Machine Learning Characterization of Solid Tumors |
NCT06835569 |
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations |
NCT06042569 |
Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial |
NCT05546268 |
Study of Oral MRT-2359 in Selected Cancer Patients |
NCT06182072 |
ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT06400472 |
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors |
NCT06663072 |
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors |
NCT05712668 |
Telemedicine Use in Preoperative Counseling for Endometrial Cancer Survivors |
NCT06877572 |
Weight Loss Management in Endometrial Cancer Survivors |
NCT06789172 |
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors |
NCT02863172 |
Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes |
NCT05868668 |
Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain |
NCT02526368 |
Pilot Study of (MR) Imaging with Pyruvate (13C) to Detect High Grade Prostate Cancer |
NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
NCT05498272 |
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations |
NCT05366881 |
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease |
NCT06173310 |
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer |
NCT06412510 |
Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT |
NCT05827081 |
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer |
NCT04636710 |
Refining Local-Regional Therapy for IBC |
NCT02170181 |
Clinical Registry for Oligometastic Disease, Consolidation Therapy, Debulking Prior to Chemotherapy, or Re-Irradiation |
NCT06572410 |
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision |
NCT05603910 |
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma |
NCT03854110 |
Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine |
NCT03897881 |
An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) |
NCT06026410 |
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors |
NCT04370587 |
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors |
NCT05042687 |
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer |
NCT03165487 |
Comparison of the Breast Tumor Microenvironment |
NCT02817633 |
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER) |
NCT06441487 |
mPATH-Cloud for Colorectal Cancer Screening |
NCT06479187 |
PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer |
NCT06168487 |
Telmisartan in Prostate Cancer |
NCT02451982 |
Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas |
NCT06926920 |
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer |
NCT05470920 |
Genetic Testing Decision Aid |
NCT04567420 |
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE) |
NCT06188520 |
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors |
NCT06437574 |
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer |
NCT05107674 |
A Study of NX-1607 in Adults With Advanced Malignancies |
NCT06441474 |
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information in Women |
NCT04339374 |
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer |
NCT05485974 |
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation |
NCT06625320 |
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT05585320 |
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors |
NCT05458674 |
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC |
NCT04471974 |
ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
NCT05111574 |
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery |
NCT06202820 |
CV CARE: CardioVascular Care in PC Patients |
NCT03161431 |
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab |
NCT06671782 |
A Study of a Pelvic Floor Muscle Exercise Program Before and After Radical Prostatectomy |
NCT05869682 |
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy |
NCT05825482 |
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® |
NCT03909282 |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma |
NCT04771520 |
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors |
NCT06750094 |
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy |
NCT04878094 |
A Study of Intra-operative Imaging in Women With Ovarian Cancer |
NCT05633160 |
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT) |
NCT05665660 |
Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening |
NCT03861676 |
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT |
NCT06023576 |
A Study of Blood Pressure Control During Cancer Treatment |
NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma |
NCT05477576 |
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy |
NCT04967976 |
Breast Mesh Used in Two-staged Breast Reconstruction |
NCT06399276 |
4:3 Intermittent Fasting Intervention in Adults With Breast Cancer and Overweight or Obesity |
NCT04701476 |
TATE and Pembrolizumab (MK3475) in mCRC and NSCLC |
NCT04872166 |
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer |
NCT06425926 |
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors |
NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer |
NCT05036226 |
COAST Therapy in Advanced Solid Tumors and Prostate Cancer |
NCT05696626 |
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation |
NCT06275126 |
Optimizing Surgical Decisions in Young Adults With Breast Cancer |
NCT04503265 |
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies |
NCT05156866 |
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer |
NCT05868226 |
PRE-I-SPY Phase I/Ib Oncology Platform Program |
NCT04768426 |
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer |
NCT06833866 |
Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer |
NCT04812366 |
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer |
NCT05268666 |
A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors |
NCT05812027 |
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors |
NCT06727773 |
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer |
NCT06524973 |
Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers |
NCT06318273 |
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer |
NCT02861573 |
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) |
NCT06294873 |
Stool Sample Collection Study |
NCT05497531 |
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers |
NCT05546827 |
PRISAM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Melanoma |
NCT02064673 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
NCT05123482 |
A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies |
NCT02361320 |
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer |
NCT04297020 |
Brain Health in Breast Cancer Survivors |
NCT05563220 |
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer |
NCT06146920 |
Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation |
NCT06270082 |
Study of IK-595 in RAS- or RAF-altered Advanced Tumors |
NCT03127631 |
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients |
NCT06545682 |
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) |
NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
NCT03995082 |
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey |
NCT05994482 |
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study |
NCT05797831 |
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer |
NCT06428682 |
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction |
NCT05653882 |
A Study Evaluating AB248 Alone or in Combination with Pembrolizumab in Adult Patients with Solid Tumors |
NCT07023731 |
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation |
NCT05770531 |
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy |
NCT06990880 |
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer |
NCT05143229 |
Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer |
NCT04562129 |
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients |
NCT04134780 |
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response |
NCT05077280 |
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma |
NCT05620329 |
UNC Pleural Fluid Registry |
NCT05544929 |
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers |
NCT05645380 |
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC |
NCT06708429 |
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System |
NCT06435429 |
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer |
NCT06194929 |
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma |
NCT05965180 |
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe |
NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
NCT05933265 |
Study of LP-184 in Patients With Advanced Solid Tumors |
NCT05634720 |
Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer |
NCT06100874 |
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) |
NCT06488365 |
In Vivo Liquid Biopsy of Melanoma (Cytophone) |
NCT06639074 |
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial |
NCT04449874 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation |
NCT05679674 |
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer |
NCT03572374 |
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job |
NCT05361174 |
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer |
NCT03452774 |
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry |
NCT05799274 |
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer |
NCT06393374 |
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) |
NCT04959474 |
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer |
NCT02749474 |
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes |
NCT06217874 |
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer |
NCT05931874 |
Optimizing a mHealth Physical Activity Intervention With Mindful Awareness Lessons in Breast Cancer Survivors |
NCT03538665 |
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons |
NCT03090165 |
Ribociclib and Bicalutamide in AR+ TNBC |
NCT06253520 |
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer |
NCT02918474 |
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer |
NCT06549465 |
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) |
NCT05020574 |
Microbiome and Association With Implant Infections |
NCT02207465 |
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer |
NCT05912231 |
Ultrahypofractionation and Normal Tissue Toxicity |
NCT05746182 |
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms |
NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
NCT04886531 |
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers |
NCT04998682 |
Prospective Evaluation of Targeted Axillary Dissection (TAD) |
NCT05803382 |
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers |
NCT06545331 |
Study of XB010 in Subjects With Solid Tumors |
NCT05669482 |
Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer |
NCT05806931 |
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer |
NCT04406831 |
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer |
NCT06636682 |
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer |
NCT05961982 |
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study |
NCT05537740 |
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors |
NCT06993844 |
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors |
NCT06361940 |
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients with Hormone Receptor-Positive HER2-negative Breast Cancer |
NCT04599140 |
SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial |
NCT05056844 |
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge |
NCT04631744 |
Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) |
NCT05059444 |
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation |
NCT04703244 |
Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer |
NCT04731844 |
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer |
NCT05458544 |
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application |
NCT05242744 |
FTT PET/CT in Metastatic Prostate Cancer |
NCT03823144 |
Intravital Microscopy in Human Solid Tumors |
NCT03682289 |
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors |
NCT06267729 |
Study of AZD0754 in Participants With Metastatic Prostate Cancer |
NCT06392789 |
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors |
NCT06171789 |
PRO1107 in Patients With Advanced Solid Tumors |
NCT06401889 |
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy |
NCT05846789 |
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers |
NCT02000089 |
The Cancer of the Pancreas Screening-5 CAPS5)Study |
NCT06485089 |
Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers |
NCT01441089 |
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis |
NCT06566092 |
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants |
NCT04657068 |
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors |
NCT04739072 |
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study |
NCT05964504 |
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry) |
NCT06952504 |
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) |
NCT05415072 |
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas |
NCT02021604 |
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma |
NCT01950572 |
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma |
NCT06728072 |
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer |
NCT05691504 |
Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers |
NCT03050268 |
Familial Investigations of Childhood Cancer Predisposition |
NCT04044872 |
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity |
NCT05490472 |
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors |
NCT05892068 |
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain |
NCT02279004 |
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care |
NCT06915168 |
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer |
NCT03270072 |
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients |
NCT04829604 |
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) |
NCT05837767 |
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue |
NCT05554367 |
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial |
NCT06342440 |
Early Detection of Advanced Adenomas and Colorectal Cancer |
NCT06589440 |
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) |
NCT03564340 |
Study of REGN4018 Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers |
NCT05023967 |
Metformin and Nightly Fasting in Women With Early Breast Cancer |
NCT06239467 |
First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer |
NCT01834001 |
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy |
NCT05046301 |
Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications |
NCT06376604 |
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies |
NCT05795101 |
TRUDI: TDXD+Durva in HER2+/low IBC |
NCT06342401 |
Early Onset Colorectal Cancer Detection |
NCT06545604 |
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer |
NCT02333604 |
Cancer Experience Registry (CER) for Cancer Patients and Caregivers |
NCT06129604 |
Pilot Window of Opportunity Trial (POET) |
NCT05130801 |
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery |
NCT04314401 |
National Cancer Institute "Cancer Moonshot Biobank" |
NCT03804944 |
Converting HR+ Breast Cancer Into an Individualized Vaccine |
NCT02701244 |
A Registry Study of Breast Microseed Treatment |
NCT02870244 |
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes |
NCT05726292 |
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer |
NCT05864144 |
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors |
NCT05376592 |
Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma |
NCT04415944 |
Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy |
NCT06533644 |
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer |
NCT04787744 |
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer |
NCT06627244 |
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma |
NCT06295744 |
Outcomes and Cosmesis With Whole Breast Irradiation and Boost |
NCT05578092 |
A Phase 1/2 Study of MRTX0902 in Solid Tumors With Mutations in the KRAS MAPK Pathway |
NCT06481592 |
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. |
NCT05086692 |
A Beta-only IL-2 ImmunoTherapY Study |
NCT05498792 |
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma |
NCT06538389 |
High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer |
NCT06157892 |
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors |
NCT06478589 |
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors |
NCT05819892 |
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer |
NCT04994067 |
Intra-Operative Radiation Registry |
NCT05736367 |
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer |
NCT05684367 |
Exercise to ReGain Stamina and Energy (The EXERGISE Study) |
NCT06046040 |
TmPSMA-02 in mCRPC |
NCT06643767 |
Evaluation of the Bexa Breast Examination |
NCT03228667 |
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors |
NCT03606967 |
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer |
NCT04674267 |
Resilience and Equity in Aging, Cancer, and Health (REACH) |
NCT06521567 |
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer |
NCT06388967 |
Pancreatic Cancer Detection Consortium |
NCT06824467 |
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) |
NCT06083844 |
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy |
NCT02402244 |
Project: Every Child for Younger Patients With Cancer |
NCT05367440 |
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer |
NCT04879940 |
Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization |
NCT04512144 |
Mindfulness in Endometrial and Cervical Cancer |
NCT03671044 |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
NCT02584244 |
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers |
NCT05355701 |
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. |
NCT06849544 |
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection |
NCT02478892 |
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients with Inherited Genetic Risk |
NCT03285412 |
CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer |
NCT05043012 |
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) |
NCT04291612 |
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease |
NCT06671912 |
Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial |
NCT06070012 |
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma |
NCT04754412 |
Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study |
NCT06989112 |
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer |
NCT06882746 |
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas |
NCT06503146 |
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection |
NCT06651580 |
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study |
NCT05983380 |
The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors |
NCT04684862 |
Infusion System for Hepatic Cancer |
NCT06574880 |
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer |
NCT05704062 |
Quantitative MRI Assessment of Breast Cancer Therapy Response |
NCT05705401 |
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer |
NCT04589468 |
Researching the Effect of Exercise on Cancer |
NCT02332668 |
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) |
NCT05112601 |
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma |
NCT05581004 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors |
NCT06103669 |
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) |
NCT05929768 |
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer |
NCT05334069 |
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection |
NCT05789069 |
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors |
NCT06844669 |
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy |
NCT05797168 |
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors |
NCT06362369 |
A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy |
NCT05469269 |
Cleveland African American Prostate Cancer Project |
NCT06001268 |
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) |
NCT06696768 |
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer |
NCT05751668 |
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) |
NCT06408168 |
Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial) |
NCT04644068 |
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies |
NCT06295965 |
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study |
NCT06297265 |
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery |
NCT05327465 |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy |
NCT06721065 |
A Study of Language Interpretation Solutions for People With Breast Cancer |
NCT06610474 |
Evaluation of an Online Prostate Cancer Screening Decision Aid |
NCT05691465 |
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells |
NCT06268665 |
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy |
NCT04329065 |
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer |
NCT06799065 |
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer |
NCT04756765 |
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer |
NCT06904365 |
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women |
NCT00756665 |
Prostate Active Surveillance Study |
NCT06666192 |
The Ohio State University (OSU) SCREEN Community Program |
NCT04106492 |
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors |
NCT05535192 |
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients |
NCT05912244 |
A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma |
NCT06562192 |
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers |
NCT04282044 |
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies |
NCT06246968 |
A Study of Pembrolizumab and Cryoablation in People With Breast Cancer |
NCT06771544 |
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma |
NCT03746431 |
A Phase 1/2 Study of [225Ac]-FPI-1434 Injection |
NCT06593431 |
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial |
NCT06402331 |
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
NCT05611931 |
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma |
NCT05721976 |
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study |
NCT05269160 |
Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ) |
NCT03876860 |
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis |
NCT04134260 |
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial |
NCT05040360 |
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors |
NCT06595160 |
Association of Plant-based Diet and Gut Microbiome Signature with Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma |
NCT06141031 |
Phase I/IB Trial of Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma |
NCT05903131 |
A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia |
NCT05206331 |
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study |
NCT04175431 |
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study |
NCT04722692 |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ |
NCT03919292 |
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca |
NCT04609592 |
Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery |
NCT06614192 |
A Randomized Trial Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Over-Expressed Refractory Metastatic Colorectal Cancer |
NCT06072612 |
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. |
NCT04877912 |
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening |
NCT06305312 |
Community Services Navigation to Advance Health Equity in Breast Cancer Screening |
NCT06517212 |
Tirzepatide Weight Loss for MRD+ Early Breast Cancer |
NCT05464810 |
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer |
NCT06585410 |
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma |
NCT06749210 |
DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY |
NCT05979610 |
Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignancies |
NCT06524895 |
Reiki Breast Surgery QOL Project for Women Undergoing Breast Surgery |
NCT01851395 |
Rapid Autopsy and Procurement of Cancer Tissue |
NCT06315595 |
Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI |
NCT06409195 |
A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers |
NCT06484595 |
Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials |
NCT03137095 |
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI |
NCT06392295 |
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer |
NCT06635980 |
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer |
NCT06121180 |
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma |
NCT05568680 |
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma |
NCT06130280 |
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer |
NCT06413680 |
A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies |
NCT05272462 |
Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer |
NCT05754580 |
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer |
NCT06264180 |
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs (IGNYTE-3) |
NCT06580743 |
Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer |
NCT06686043 |
HPV Vaccine, Imiquimod, and Metformin Combination Trial |
NCT06675643 |
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity: A Feasibility Study of the Vigilant App (Vigilant-2) |
NCT06371768 |
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors |
NCT05838768 |
Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency. |
NCT06568692 |
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer |
NCT05472792 |
Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy |
NCT01954992 |
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer |
NCT05705492 |
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer |
NCT05155501 |
Clinical Trial of Approaches to Prostate Cancer Surgery |
NCT06086704 |
Study of 18F-FFNP Breast PET/MRI |
NCT02595957 |
Genomic Services Research Program |
NCT06590857 |
Trial of 225Ac-DOTATATE (RYZ101) in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. |
NCT06399757 |
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors |
NCT04443348 |
Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) |
NCT05721248 |
STOP-HER2: Stopping Trastuzumab in HER2+ MBC |
NCT05669430 |
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies |
NCT04606030 |
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) |
NCT06533826 |
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd |
NCT06542757 |
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy |
NCT04545957 |
Jump: MR Simulation For Radiation Therapy Master Protocol |
NCT06557057 |
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk |
NCT04346225 |
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer |
NCT06806930 |
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) |
NCT06805825 |
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit |
NCT05004025 |
Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma |
NCT05877430 |
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer |
NCT03678025 |
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer |
NCT05053230 |
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer |
NCT04039230 |
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. |
NCT05799248 |
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management |
NCT06710548 |
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors |
NCT06605430 |
Medical Cannabis in Patients With Advanced Pancreatic Cancer |
NCT04734730 |
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer |
NCT05673148 |
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study |
NCT06056830 |
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy |
NCT03524430 |
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy |
NCT06297525 |
Study of STP938 in Advanced Solid Tumours |
NCT06610825 |
Castrate Resistant Prostate Cancer Enhertu Therapy |
NCT05922930 |
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer |
NCT05746325 |
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast Cancer |
NCT06358430 |
Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) |
NCT05488548 |
Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies |
NCT05464030 |
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) |
NCT05461430 |
Mass Response of Tumor Cells As a Biomarker for Rapid Therapy Guidance (TraveraRTGx) |
NCT06654622 |
Exosome-based Detection of Molecular Residual Disease in Stage II-III Colorectal Cancer |
NCT05136196 |
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study |
NCT06898996 |
FITting Non-invasive Tests in Lynch Syndrome Surveillance |
NCT05930496 |
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors |
NCT04130516 |
Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and with Pembrolizumab |
NCT05646316 |
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer |
NCT06461416 |
A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework |
NCT03467516 |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma |
NCT04251416 |
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma |
NCT06326216 |
Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer |
NCT03354416 |
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer |
NCT04975516 |
Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer |
NCT03784924 |
EDRN Prostate MRI Biomarker Study |
NCT05225363 |
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer |
NCT04575935 |
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial |
NCT06623396 |
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer |
NCT06826924 |
7-Days Water-Only Fasting Trial in Prostate Cancer |
NCT04677816 |
Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients |
NCT06113016 |
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors |
NCT05013216 |
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer |
NCT04794816 |
What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care |
NCT06236139 |
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT06492122 |
Study With [225Ac]Ac-FL-020 in mCRPC Participants |
NCT06398639 |
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer |
NCT04797039 |
MRI-Guided Cryoablation for Focal Native Prostate Cancer |
NCT04918186 |
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer |
NCT05336786 |
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount) |
NCT06610539 |
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients |
NCT05174286 |
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk |
NCT06778863 |
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation |
NCT06059963 |
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation |
NCT04862663 |
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292) |
NCT05438563 |
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Intermediate Grade Prostate Cancer |
NCT04789486 |
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer |
NCT06820463 |
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer |
NCT04792463 |
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome |
NCT04706663 |
Precision-Based Genomics in Prostate Cancer |
NCT05226663 |
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer |
NCT06423963 |
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer |
NCT06421935 |
M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) |
NCT05428735 |
The DRAGON 2 Trial |
NCT05998135 |
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer |
NCT05610735 |
Combination Therapy for Recurrent Ovarian Cancer |
NCT05840263 |
Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer |
NCT06500858 |
MBC Physical Activity Study |
NCT06132958 |
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) |
NCT06014086 |
Intratumoral PH-762 for Cutaneous Carcinoma |
NCT04158635 |
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer |
NCT04074135 |
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors |
NCT04751435 |
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients |
NCT03526835 |
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors |
NCT06250335 |
Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients |
NCT03420963 |
Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors |
NCT06797635 |
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) |
NCT02743858 |
Lymphedema Surveillance Study |
NCT04847063 |
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies |
NCT06100263 |
Breast Cancer Resiliency Through Exercise Program (B-REP) |
NCT06662435 |
GYNecologic Cancer-Related COGnitive Impairment |
NCT02830724 |
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers |
NCT05497024 |
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing |
NCT04568616 |
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) |
NCT04646434 |
Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy |
NCT05716516 |
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER) |
NCT05125016 |
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer |
NCT06246916 |
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) |
NCT05351424 |
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc |
NCT03943316 |
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies |
NCT05692024 |
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER |
NCT06551324 |
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). |
NCT06312124 |
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer |
NCT05786924 |
A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers |
NCT06691035 |
Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer |
NCT06617858 |
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment |
NCT05377996 |
A Study of XMT-1660 in Participants With Solid Tumors |
NCT06287463 |
Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway |
NCT06542835 |
Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity |
NCT04331535 |
The Genomic Medicine at VA Study |
NCT06756035 |
CT-95 in Advanced Cancers Associated With Mesothelin Expression |
NCT04188535 |
Serial MRI Scans During Radiation Therapy |
NCT05524935 |
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma |
NCT04969835 |
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours |
NCT04799535 |
Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring |
NCT04887935 |
Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer |
NCT05384535 |
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort |
NCT05455658 |
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer |
NCT05830058 |
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma |
NCT06698458 |
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer |
NCT03686124 |
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors |
NCT06291324 |
WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment |
NCT06925724 |
A Study of Ivonescimab in People With Endometrial and Cervical Cancers |
NCT05268224 |
A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue |
NCT05776524 |
Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer |
NCT03965234 |
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases |
NCT06639724 |
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer |
NCT06704724 |
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. |
NCT06410534 |
A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer |
NCT06391034 |
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer |
NCT06298916 |
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer |
NCT06466434 |
Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma |
NCT05036096 |
Cone Beam Breast CT for Breast Cancer Screening |
NCT06568016 |
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers |
NCT06584396 |
Evaluating Mechanical Properties of Post-Mastectomy Skin Flaps to Estimate Reconstruction Risks, the EMPOWER Study |
NCT04751396 |
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors |
NCT04457596 |
T-DM1 and Tucatinib Compared with T-DM1 Alone in Preventing Relapses in People with High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial |
NCT05548296 |
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma |
NCT06703996 |
InBody Band 3 Fitness Tracker to Improve Health Outcomes and Quality of Life in Black Prostate Cancer Survivors |
NCT00034216 |
Collection of Blood From Patients With Cancer |
NCT03454035 |
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors |
NCT04022616 |
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients |
NCT05838716 |
High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients |
NCT06492616 |
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence |
NCT06205316 |
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma |
NCT06084416 |
A Study of Sovilnesib in Subjects with Ovarian Cancer |
NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
NCT05462496 |
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer |
NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
NCT05864196 |
Two Fraction Prostate SBRT With DIL SIB |
NCT06122896 |
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals |
NCT03990896 |
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial |
NCT06364696 |
A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors |
NCT03819296 |
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer |
NCT04318717 |
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma |
NCT06879041 |
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT05803941 |
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer |
NCT04513717 |
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial |
NCT06610617 |
Neuromodulation of Central Sensory Integration to Improve Postural Control |
NCT06579417 |
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer |
NCT06486441 |
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) |
NCT01042548 |
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum |
NCT06307548 |
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer |
NCT05752448 |
Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) |
NCT03767348 |
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab |
NCT06065748 |
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) |
NCT06726148 |
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors |
NCT04567706 |
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma |
NCT06059118 |
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer |
NCT05988918 |
Multicenter Trial of ESK981 in Patients With Select Solid Tumors |
NCT05168618 |
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial |
NCT06827613 |
A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors |
NCT06205836 |
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer |
NCT01913106 |
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer |
NCT05590949 |
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors |
NCT05341349 |
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-100M for the Treatment of Melanoma Brain Metastases |
NCT05245006 |
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer |
NCT06855706 |
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study |
NCT04073706 |
Sentinel Node Biopsy in Endometrial Cancer |
NCT04557449 |
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors |
NCT03190941 |
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients |
NCT04206319 |
Radium-223 in Biochemically Recurrent Prostate Cancer |
NCT06591819 |
Hypofractionated WPPT With HDR Boost |
NCT05624918 |
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma |
NCT00949819 |
Active Surveillance for Cancer of the Prostate (ASCaP) |
NCT04851119 |
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors |
NCT03805919 |
Men at High Genetic Risk for Prostate Cancer |
NCT06824818 |
Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients |
NCT05636618 |
Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors |
NCT04796818 |
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response |
NCT05848141 |
Rowing Following Breast Cancer Chemotherapy |
NCT05627219 |
Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network |
NCT04038619 |
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients |
NCT05271318 |
Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a and 2) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. |
NCT06599619 |
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi |
NCT05683418 |
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors |
NCT06904313 |
Ultralow Dose PET Imaging for PSMA Expression |
NCT05637216 |
Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients |
NCT06566716 |
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass |
NCT06551116 |
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer |
NCT05232916 |
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects |
NCT03175224 |
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors |
NCT05349227 |
Comprehensive Outcomes for After Cancer Health |
NCT05034627 |
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer |
NCT05556473 |
F-Tryptophan PET/CT in Human Cancers |
NCT05914116 |
A Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors |
NCT05305924 |
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
NCT04711824 |
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases |
NCT03492424 |
Ablative Therapy in the Management of Prostate Cancer |
NCT05981716 |
Young Breast Cancer Survivors Study |
NCT05590624 |
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer |
NCT06974734 |
A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies |
NCT05751434 |
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer |
NCT05415917 |
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy |
NCT04548817 |
Neurocutaneous Melanocytosis Registry |
NCT06906341 |
Relacorilant in Combination With Nab-paclitaxel and Bevacizumab in Advanced, Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer |
NCT04981834 |
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate Cancer |
NCT07020117 |
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors |
NCT06067841 |
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer |
NCT06736717 |
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer |
NCT06801236 |
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer |
NCT06723236 |
A Study of MGC028 in Participants With Advanced Solid Tumors |
NCT06858449 |
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer |
NCT04890613 |
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation |
NCT05141513 |
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma |
NCT04081636 |
Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications |
NCT06355336 |
Real World Prostate Cancer Registry |
NCT06252649 |
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation |
NCT06637306 |
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer |
NCT02838836 |
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers |
NCT06153836 |
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction |
NCT06205849 |
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer |
NCT02600949 |
Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer |
NCT04114136 |
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies |
NCT04055649 |
ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer |
NCT04349436 |
A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies |
NCT06880549 |
A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors |
NCT05754749 |
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions |
NCT05946824 |
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned. |
NCT04858334 |
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation |
NCT04975217 |
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer |
NCT06384417 |
Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 |
NCT05514717 |
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 |
NCT06379217 |
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. |
NCT05997017 |
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer |
NCT00912717 |
Pancreatic Adenocarcinoma Gene Environment Risk Study |
NCT06298734 |
High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial |
NCT04305834 |
Abemaciclib and Endocrine Therapy in Older Patients with Breast Cancer. |
NCT05170334 |
Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma |
NCT06757634 |
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) |
NCT06075524 |
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types |
NCT06011434 |
Testing Conversation Aid in Practice |
NCT05468034 |
Exercise in Metastatic Breast Cancer: EMBody |
NCT02290834 |
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer |
NCT05321134 |
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery |
NCT05565534 |
Diabetes Care for Breast Cancer Patients |
NCT04119024 |
Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors |
NCT05297734 |
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer |
NCT05989724 |
A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors |
NCT06274034 |
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors |
NCT05812924 |
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause |
NCT05748834 |
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer |
NCT05565417 |
Study of the Monoclonal Antibody IMT-009 in Patients with Advanced Solid Tumors or Lymphomas |
NCT03646617 |
Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma |
NCT05787834 |
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer |
NCT05743517 |
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) |
NCT06433219 |
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) |
NCT04489719 |
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer |
NCT05804318 |
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer |
NCT06625034 |
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer |
NCT05356117 |
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial |
NCT06582017 |
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma |
NCT04981119 |
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing |
NCT06144619 |
Non-Invasive Biomarkers in Prostate Cancer Disease Management |
NCT04903119 |
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma |
NCT06887218 |
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer |
NCT06648434 |
MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma |
NCT05607017 |
Losartan in Prevention of Radiation-Induced Heart Failure |
NCT06395519 |
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies |
NCT05455619 |
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer |
NCT06388018 |
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer |
NCT04997018 |
A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer |
NCT06111313 |
The University of Miami Adapt (UAdapt) Trial |
NCT07064018 |
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies |
NCT05790213 |
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation |
NCT06105918 |
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients with Biochemically Recurrent Prostate Cancer |
NCT05536713 |
Understanding Patient Preference on Colorectal Cancer Screening Options |
NCT05411718 |
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome |
NCT04222413 |
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors |
NCT04371913 |
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study |
NCT03096418 |
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response |
NCT05879913 |
ASCVD Management Using CCTA in Prostate Cancer Patients on ADT |
NCT06060613 |
Safety and Efficacy of OBX-115 in Advanced Solid Tumors |
NCT05035836 |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
NCT04851613 |
Study Evaluating Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients w/ Locally Advanced or Metastatic HR+/HER2- Breast Cancer |
NCT04692818 |
3D Ultrasound Breast Imaging |
NCT06666218 |
Helping Ovarian Cancer Patients Cope With Their Illness (HOPE) |
NCT06800313 |
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) |
NCT06084013 |
Use of Indocyanine Green in Pancreas Surgery |
NCT05056818 |
Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics |
NCT06507618 |
Pre-Operative Window of ET to Inform RT Decisions (POWER II) |
NCT06534918 |
Precise Oncology Interventions in Nutrition and Training (OnPoint) |
NCT06303713 |
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer |
NCT06603818 |
Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC) |
NCT05946213 |
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer |
NCT06526819 |
SMP-3124LP in Adults With Advanced Solid Tumors |
NCT04599218 |
MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer |
NCT05977036 |
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer |
NCT06064149 |
The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study |
NCT04270149 |
Cancer Peptides Plus GM-CSF and Adjuvant in Breast Cancer |
NCT04071236 |
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy |
NCT06699836 |
A Phase 2 Study of Leronlimab in Combination With TAS-102 + Bevacizumab in Previously Treated Participants With mCRC |
NCT06105749 |
Biennial CEM in Women with a Personal History of Breast Cancer |
NCT05141149 |
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic Cancer |
NCT05193149 |
Inspiratory Muscle Training in Obese Breast Cancer Survivors |
NCT06994832 |
Using Visual Arrays to Support Understanding of Genetic Risk |
NCT05325632 |
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab |
NCT05820932 |
Predicting Cognitive Decline From Androgen Deprivation Therapy |
NCT06760637 |
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease |
NCT04683315 |
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples |
NCT05428007 |
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma |
NCT05226507 |
A Phase 1 Clinical Study of NXP800 in Subjects with Advanced Cancers and Expansion in Subjects with Ovarian Cancer |
NCT05723107 |
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) |
NCT05887609 |
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib |
NCT06760507 |
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics |
NCT05123807 |
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study) |
NCT05722288 |
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers |
NCT05095207 |
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer |
NCT04990609 |
EUS-RFA PANCARDINAL-1 Trial |
NCT06598007 |
A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors |
NCT06464107 |
Endometrial Cell Collection With the PadKit |
NCT06555588 |
Engage Psychosocial Intervention for Cancer Symptoms |
NCT04858009 |
Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis |
NCT05035407 |
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers |
NCT03932409 |
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer |
NCT04837209 |
Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer |
NCT04720209 |
Taking AIM at Breast Cancer |
NCT05291507 |
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System |
NCT03941756 |
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma |
NCT06411756 |
Physical Activity Centers Empowerment |
NCT03740256 |
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors |
NCT06689956 |
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study |
NCT06271356 |
Breast Cancer - Navigate - Prospective Cohort |